Interim Report for the period January – March 2020
Operations performing according to plan Key events during the first quarter 2020 · As of today, BioArctic has not experienced any noteworthy disruptions to its operations owing to the COVID-19 pandemic. Financial summary January – March 2020 · Net revenues for the period amounted to MSEK 36.4 (63.4), a decrease of 27 MSEK · Operating profit amounted to 3.8 MSEK (17.3) and the operating margin was 10.4 percent (27.3) · Profit for the period amounted to MSEK 3.6 (13.6) and earnings per share were SEK 0.04 (0.15) · Cash flow from operating activities amounted to MSEK -